- Home
- NEGG vs COYA Comparison
NEGG vs COYA Comparison
Compare NEGG & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- COYA
- Stock Information
- Founded
- NEGG 2001
- COYA 2020
- Country
- NEGG United States
- COYA United States
- Employees
- NEGG N/A
- COYA N/A
- Industry
- NEGG Other Specialty Stores
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- COYA Health Care
- Exchange
- NEGG Nasdaq
- COYA Nasdaq
- Market Cap
- NEGG 116.0M
- COYA 108.4M
- IPO Year
- NEGG 2010
- COYA 2022
- Fundamental
- Price
- NEGG $0.25
- COYA $6.47
- Analyst Decision
- NEGG
- COYA Strong Buy
- Analyst Count
- NEGG 0
- COYA 4
- Target Price
- NEGG N/A
- COYA $17.00
- AVG Volume (30 Days)
- NEGG 703.9K
- COYA 91.9K
- Earning Date
- NEGG 04-23-2025
- COYA 03-18-2025
- Dividend Yield
- NEGG N/A
- COYA N/A
- EPS Growth
- NEGG N/A
- COYA N/A
- EPS
- NEGG N/A
- COYA N/A
- Revenue
- NEGG $1,391,833,000.00
- COYA $3,554,061.00
- Revenue This Year
- NEGG $6.01
- COYA $61.45
- Revenue Next Year
- NEGG N/A
- COYA N/A
- P/E Ratio
- NEGG N/A
- COYA N/A
- Revenue Growth
- NEGG N/A
- COYA N/A
- 52 Week Low
- NEGG $0.24
- COYA $4.75
- 52 Week High
- NEGG $1.32
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- NEGG 27.51
- COYA 48.49
- Support Level
- NEGG $0.25
- COYA $6.36
- Resistance Level
- NEGG $0.32
- COYA $7.06
- Average True Range (ATR)
- NEGG 0.03
- COYA 0.44
- MACD
- NEGG -0.00
- COYA -0.02
- Stochastic Oscillator
- NEGG 8.12
- COYA 32.95
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.